secwatch.observer — SEC 8-K summary
======================================

Issuer:     IRADIMED CORP (IRMD)
CIK:        0001325618
Form:       8-K
Filed at:   2022-04-29T23:59:59+00:00
Accession:  0001104659-22-052778
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

iRadimed Q1 revenue $12.3M (+33% YoY), EPS $0.20; raises FY22 guidance
----------------------------------------------------------------------

- Q1 revenue $12.3M vs $9.2M YoY; GAAP diluted EPS $0.20 vs $0.11; non-GAAP EPS $0.22 vs $0.13.
- Raised FY22 guidance: revenue $52.5-53.2M (prev $51.4-52.2M), GAAP EPS $0.89-0.95, non-GAAP EPS $0.96-1.03.
- Q2 guidance: revenue $12.5-12.7M, GAAP EPS $0.21-0.23, non-GAAP EPS $0.23-0.25.
- Paid special dividend of $1.00 per share during Q1 2022; monitors segment revenue surged to $5.19M from $2.60M YoY.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1325618/000110465922052778/0001104659-22-052778-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1325618/000110465922052778/tm2213916d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-052778

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer